drugset / Trial / NCT02860039

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

NCT02860039 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

Timeline

Start
2016-09
Primary completion
2021-12-01
Completion
2024-09

Outcome

Met primary endpoint

paper were more immunogenic than 2 doses of standard-dose quadrivalent influenza vaccine (SD-QIV). PMID 39279435 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quadrivalent influenza vaccine Vaccine — Intramuscular
Subject Trivalent Influenza Vaccine Vaccine — Intramuscular